When experts at the Massachusetts General Hospital Cancer Center needed funding to explore an innovative approach for detecting cancer, they turned to the MGH Fund.
Supporting Innovative Research
Two of the researchers behind
the CTC-chip A few years ago, clinicians and scientists at the Massachusetts General Hospital Cancer Center decided to collaborate on an idea. Their goal was to find a way of capturing the tumor cells that circulate in the blood stream of a person with cancer. It had never been done before.
Thanks to MGH Fund support, those Mass General experts had the resources they needed to develop a breakthrough technology called the CTC-chip. The size of a business card, this silicon chip has made it possible for cancer specialists to retrieve circulating tumor cells as those cells travel throughout the body.
It is a landmark achievement that is receiving quite a bit of national attention, including a $15 million grant from the organization Stand Up to Cancer, for continued exploration of this important new technology. The Mass General team was one of just five teams chosen for such significant funding, demonstrating the promise this breakthrough holds for the future.
Make a gift 
Your gift of any amount will open new doors in outstanding patient care, research, clinical education and community outreach at Mass General.
Individual Care. Global Impact.
Join us in the Campaign for the Third Century of MGH Medicine. Learn how we’re making a difference in patient care and advancing medicine and human health around the world.
Support the Campaign for the Third Century
When you support the Campaign for the Third Century of MGH Medicine, you help make a difference in patient care and advance medicine and human health around the world.
